A US manufacturing facility cued up for closure by Boehringer Ingelheim has been bought by a Chinese drugmaker. Boehringer had …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

